Matteo Simonelli

22PUBLICATIONS
71CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Apr 01, 2026
Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 study.

Capucine Baldini, Philippe A Cassier, Jean-Pierre Delord

|Oct 13, 2025
Case study: Successful full-course chemotherapy administration in a liver transplant recipient diagnosed with central nervous system World Health Organization Grade 2 IDH mutant/1p-19q co-deleted oligodendroglioma.

Angelo Dipasquale, Agnese Losurdo, Pasquale Persico

|Aug 14, 2025
Lenvatinib plus pembrolizumab for patients with previously treated select solid tumors: Results from the phase 2 LEAP-005 study recurrent glioblastoma cohort.

Sun Young Rha, Eduardo Castanon, Sanjeev Gill

|Aug 07, 2025
Primary mismatch repair deficiency and Lynch syndrome in adult diffuse gliomas: A call to action.

Pasquale Persico, Angelo Dipasquale, Agnese Losurdo

|May 14, 2025
Exploring the Role of ADCs in Brain Metastases and Primary Brain Tumors: Insight and Future Directions.

Francesco Bruzzone, Chiara Barigazzi, Antonio Di Muzio

|Mar 28, 2025
Proliferation-Diffusion Modeling in Glioblastoma: Impact of Supramaximal Resection on Survival.

Maria Pia Tropeano, Zefferino Rossini, Ettore Bresciani

Pageof 4

Frequent Collaborators

10 joint publications

Pasquale Persico

8 joint publications

Angelo Dipasquale

7 joint publications

Giuseppe Lombardi

4 joint publications

Pierina Navarria